Organigram (OGI) Competitors C$2.22 +0.13 (+6.22%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades OGI vs. CMED, WEED, EMC, ICC, LEAF, MGW, BE, BLO, SL, and MJNShould you be buying Organigram stock or one of its competitors? The main competitors of Organigram include CanniMed Therapeutics (CMED), Canopy Growth (WEED), Emblem (EMC), ICC Labs (ICC), Leaf Mobile (LEAF), Maple Leaf Green World (MGW), Beleave (BE), Cannabix Technologies (BLO), Supreme Cannabis Company Inc, (SL), and Cronos Group (MJN). These companies are all part of the "cannabis" industry. Organigram vs. CanniMed Therapeutics Canopy Growth Emblem ICC Labs Leaf Mobile Maple Leaf Green World Beleave Cannabix Technologies Supreme Cannabis Company Inc, Cronos Group Organigram (TSE:OGI) and CanniMed Therapeutics (TSE:CMED) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, community ranking, valuation and profitability. Does the MarketBeat Community prefer OGI or CMED? CanniMed Therapeutics received 108 more outperform votes than Organigram when rated by MarketBeat users. Likewise, 75.85% of users gave CanniMed Therapeutics an outperform vote while only 44.95% of users gave Organigram an outperform vote. CompanyUnderperformOutperformOrganigramOutperform Votes4944.95% Underperform Votes6055.05% CanniMed TherapeuticsOutperform Votes15775.85% Underperform Votes5024.15% Is OGI or CMED more profitable? CanniMed Therapeutics has a net margin of 0.00% compared to Organigram's net margin of -153.80%. CanniMed Therapeutics' return on equity of 0.00% beat Organigram's return on equity.Company Net Margins Return on Equity Return on Assets Organigram-153.80% -54.53% -5.56% CanniMed Therapeutics N/A N/A N/A Does the media favor OGI or CMED? In the previous week, Organigram had 12 more articles in the media than CanniMed Therapeutics. MarketBeat recorded 12 mentions for Organigram and 0 mentions for CanniMed Therapeutics. Organigram's average media sentiment score of 0.07 beat CanniMed Therapeutics' score of 0.00 indicating that Organigram is being referred to more favorably in the media. Company Overall Sentiment Organigram Neutral CanniMed Therapeutics Neutral Do insiders and institutionals have more ownership in OGI or CMED? 8.4% of Organigram shares are owned by institutional investors. 31.3% of Organigram shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts prefer OGI or CMED? Organigram currently has a consensus price target of C$3.43, indicating a potential upside of 54.28%. Given Organigram's stronger consensus rating and higher possible upside, equities research analysts plainly believe Organigram is more favorable than CanniMed Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75CanniMed Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger valuation & earnings, OGI or CMED? CanniMed Therapeutics has lower revenue, but higher earnings than Organigram. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrganigramC$149.21M1.62-C$229.48M-C$2.51-0.88CanniMed TherapeuticsN/AN/AN/AN/AN/A SummaryOrganigram beats CanniMed Therapeutics on 8 of the 13 factors compared between the two stocks. Ad Crypto 101 MediaThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Organigram News Delivered to You Automatically Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGI vs. The Competition Export to ExcelMetricOrganigramDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$241.03MC$1.15BC$5.12BC$6.05BDividend YieldN/A3.04%4.91%5.43%P/E Ratio-0.88131.2391.3426.16Price / Sales1.621,962.971,117.701,327.99Price / Cash3.8510.1142.6482.04Price / Book0.783.064.793.07Net Income-C$229.48MC$152.21MC$120.07MC$294.08M7 Day Performance5.71%-0.51%-1.90%-2.47%1 Month Performance5.46%-1.36%11.45%-0.78%1 Year Performance35.37%98.69%30.63%34.57% Organigram Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGIOrganigram3.1639 of 5 starsC$2.22+6.2%C$3.43+54.3%+36.2%C$241.03MC$149.21M-0.88987Analyst ForecastAnalyst RevisionNews CoverageCMEDCanniMed TherapeuticsN/AC$27.00-5.3%N/AN/AC$668.44MN/A0.00147,000WEEDCanopy Growth1.1051 of 5 starsC$4.32-2.3%C$7.12+64.8%-36.9%C$366.60MC$287.10M-0.562,700Analyst DowngradeEMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AICCICC LabsN/AC$1.62-5.8%N/A+0.0%C$223.64MC$533,684.0095.29N/AGap UpLEAFLeaf MobileN/AC$2.59-1.9%N/AN/AC$198.42MC$83.74M58.86150MGWMaple Leaf Green WorldN/AC$0.79+777.8%N/A+0.0%C$111.69MN/A0.00N/APositive NewsGap UpBEBeleaveN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeBLOCannabix TechnologiesN/AN/AN/AN/AC$0.00N/A0.00N/AGap DownSLSupreme Cannabis Company Inc,N/AN/AN/AN/AC$0.00N/A0.00N/AGap DownHigh Trading VolumeMJNCronos GroupN/AC$12.15-1.9%N/A+0.0%C$1.73BN/A0.007,600 Related Companies and Tools Related Companies CanniMed Therapeutics Competitors Canopy Growth Competitors Emblem Competitors ICC Labs Competitors Leaf Mobile Competitors Maple Leaf Green World Competitors Beleave Competitors Cannabix Technologies Competitors Supreme Cannabis Company Inc, Competitors Cronos Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:OGI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
